Pages that link to "Q68009550"
Jump to navigation
Jump to search
The following pages link to Immunotoxins constructed with anti-CD25 monoclonal antibodies and deglycosylated ricin A-chain have potent anti-tumour effects against human Hodgkin cells in vitro and solid Hodgkin tumours in mice (Q68009550):
Displaying 17 items.
- Immunotoxins in cancer therapy (Q33745138) (← links)
- Recombinant immunotoxins in targeted cancer cell therapy (Q34295821) (← links)
- Immunotoxins for targeted cancer therapy (Q34646650) (← links)
- An anti-CD45RO immunotoxin eliminates T cells latently infected with HIV-1 in vitro (Q35653299) (← links)
- Combined use of an immunotoxin and cyclosporine to prevent both activated and quiescent peripheral blood T cells from producing type 1 human immunodeficiency virus (Q36106061) (← links)
- A reevaluation of CD22 expression in human lung cancer (Q37518988) (← links)
- Compatible-solute-supported periplasmic expression of functional recombinant proteins under stress conditions (Q39485825) (← links)
- Hodgkin's disease. Future treatment strategies: fact or fiction? (Q40927803) (← links)
- Clinical targeting recombinant immunotoxins for cancer therapy (Q41149227) (← links)
- Cocktails of ricin a‐chain immunotoxins against different antigens on hodgkin and sternberg‐reed cells have superior anti‐tumor effects against H‐RS cells in vitro and solid Hodgkin tumors in mice (Q41283633) (← links)
- A dominant linear B-cell epitope of ricin A-chain is the target of a neutralizing antibody response in Hodgkin's lymphoma patients treated with an anti-CD25 immunotoxin (Q47759386) (← links)
- Recombinant anti-CD25 immunotoxin RFT5(SCFV)-ETA' demonstrates successful elimination of disseminated human Hodgkin lymphoma in SCID mice. (Q54052671) (← links)
- Uses and limitations of monoclonal antibodies (MoAbs) in the treatment of malignant disease: a review (Q70746280) (← links)
- The in vivo anti-tumor activity of immunotoxins containing two versus one deglycosylated ricin A chains (Q70805946) (← links)
- Development of new ricin A‐chain immunotoxins with potent anti‐tumor effects against human hodgkin cells in vitro and disseminated Hodgkin tumors in scid mice using high‐affinity monoclonal antibodies directed against the CD30 antigen (Q71819946) (← links)
- Characterization of the increased cytotoxicity of gelonin anti-T cell immunoconjugates compared with ricin A chain immunoconjugates (Q72065807) (← links)
- Long-term oral administration of ginseng extract decreases serum gamma-globulin and IgG1 isotype in mice (Q73766117) (← links)